Eye and Vision, published by BMC, is a leading open-access journal dedicated to the dynamic field of ophthalmology and visual sciences. With its ISSN 2326-0246 and E-ISSN 2326-0254, the journal has established itself as a premier platform for innovative research and clinical studies, achieving impressive rankings in 2023 as Q1 in both Health Professions (Miscellaneous) and Ophthalmology categories. The journal's commitment to accessible knowledge since its transition to open access in 2015 enhances its global reach, allowing researchers, clinicians, and students to share and access top-tier studies and advancements in the field. Located in the United Kingdom and delivering influential insights from 2014 through to 2024, Eye and Vision holds significant relevance, with a Scopus ranking placing it in the 99th percentile for Health Professions and the 93rd percentile for Ophthalmology, making it an essential resource for those looking to stay at the forefront of eye research and vision science.

Ophthalmologie is a distinguished journal published by Springer Heidelberg, specializing in the broad and evolving field of ophthalmology. With an ISSN of 2731-720X and an E-ISSN of 2731-7218, the journal serves as a pivotal platform for disseminating cutting-edge research and clinical advancements in the realm of eye health. As of 2023, it ranks in the third quartile (Q3) within both the general medicine and ophthalmology categories, reflecting its substantial contribution to the academic community and the field's knowledge base. The journal aims to foster collaboration among researchers, medical professionals, and students by offering innovative findings that enhance understanding and treatment of ocular diseases. By nurturing high-quality scholarly discussions, Ophthalmologie plays an essential role in the ongoing development of therapeutic strategies and ophthalmic techniques that ultimately benefit patient care globally. This commitment to excellence is evident as it continues to evolve through its convergence from 1992 to 2023, staying relevant in an ever-changing scientific environment.

Klinische Monatshefte für Augenheilkunde is a distinguished peer-reviewed journal published by Georg Thieme Verlag KG, dedicated to advancing knowledge in the field of ophthalmology and general medicine. With an ISSN of 0023-2165 and an E-ISSN of 1439-3999, this journal has been a reputable platform for researchers and clinicians since its inception in 1963, continuing its impactful contributions through to 2024. Recognized in the Q3 quartile for both Medicine (miscellaneous) and Ophthalmology, this journal serves as a vital resource for those involved in ocular health, offering insights into clinical practices, recent advancements, and essential research findings. Despite its traditional publishing model, the journal retains a significant role in the academic community, as evidenced by its current Scopus ranking of #90/137 in the field of Ophthalmology. It is an essential read for professionals and students aiming to stay at the forefront of ophthalmic research and clinical innovations.

BMC Ophthalmology is a premier open access journal dedicated to advancing the field of ophthalmology through the publication of high-quality, peer-reviewed research. Published by BMC in the United Kingdom, this journal has been a vital resource since its inception in 2001 and continuously contributes to the global dialogue in vision science. With an impact factor reflecting its growing influence, BMC Ophthalmology is ranked among the top quartiles (Q2) in both general medicine and ophthalmology, emphasizing its significance in medical research. The journal encourages submissions that explore innovative diagnostics, treatment approaches, and understandings of various ocular diseases, thereby appealing to researchers, clinicians, and students alike. As an open access platform, it ensures that cutting-edge research is not only published but also readily accessible to a worldwide audience, promoting further study and collaboration in this essential area of medicine.

Taiwan Journal of Ophthalmology is a premier open-access publication dedicated to advancing the field of ophthalmology. Published by Wolters Kluwer Medknow Publications, this journal has been a vital resource for researchers, practitioners, and students since its inception in 2012. With an ISSN of 2211-5056 and an E-ISSN of 2211-5072, it provides a platform for sharing innovative research, clinical findings, and reviews pertinent to eye health and vision science. The journal is indexed in Scopus and currently holds a Q3 quartile ranking within the ophthalmology category, reflecting its commitment to quality and relevance in the medical community. Located in Mumbai, India, Taiwans Journal of Ophthalmology aims to foster discussions and disseminate knowledge that promotes better understanding and treatment of ocular diseases, ensuring that the latest advancements reach a global audience. By embracing open-access policies, the journal underscores its dedication to making valuable insights readily available to all interested parties, thus contributing significantly to the discourse in ophthalmic research.

EYE is a prestigious peer-reviewed journal published by SpringerNature that serves as a cornerstone in the fields of Ophthalmology, Arts and Humanities, and Neuroscience. Since its inception in 1987, this influential journal has consistently maintained a Q1 Quartile ranking across multiple categories, showcasing its commitment to advancing knowledge and research in its disciplines. With a notable impact factor and a robust Scopus ranking—19th in Ophthalmology and 8th in Sensory Systems—EYE is vital for researchers, clinicians, and students alike, providing a platform for groundbreaking studies and critical reviews. While the journal operates under a subscription model, it ensures broad access to high-quality research, facilitating the dissemination of knowledge that shapes the future of eye health and sensory systems. With an address at Campus, 4 Crinan St, London N1 9XW, England, EYE continues to be a leading light in the understanding and advancement of visual health and sensory sciences.

RETINA - THE JOURNAL OF RETINAL AND VITREOUS DISEASES is a premier peer-reviewed journal dedicated to advancing the knowledge and practice of retinal and vitreous disorders. Published by LIPPINCOTT WILLIAMS & WILKINS, this esteemed journal boasts a significant impact factor, affirming its standing in the academic community. With a long history of publication since 1981, its scope covers cutting-edge research and innovations aimed at improving patient outcomes in ophthalmology. As evidenced by its recent categorization in the Q1 quartile for both Medicine (miscellaneous) and Ophthalmology in 2023, the journal ranks impressively, placing it in the 84th percentile among its peers. Researchers, clinicians, and students will find valuable insights and evidence-based articles that contribute to the ever-evolving landscape of retinal health. RETINA remains committed to fostering an environment for scholarly dialogue and dissemination of knowledge, ensuring its readers are at the forefront of advancements in their field.

SURVEY OF OPHTHALMOLOGY is a premier journal published by Elsevier Science Inc, dedicated to advancing knowledge in the field of ophthalmology. With an impact factor reflective of its high-quality research—ranking 7th out of 137 in the Scopus category for medicine and ophthalmology, this journal maintains a prestigious Q1 categorization in its field for 2023. Since its inception in 1956, the journal has provided comprehensive reviews and original articles covering various aspects of ophthalmic research and clinical practice, supporting the ongoing education of researchers, professionals, and students alike. While open access options are not available, the journal remains an essential resource for the latest developments, discoveries, and expert insights that shape the future of eye health. Based in the United States, at STE 800, 230 Park Ave, New York, NY 10169, the journal continues a legacy of excellence in ophthalmology until 2024 and beyond, making it a pivotal element of scholarly discourse in this vital medical discipline.

JAMA Ophthalmology, the premier journal in the field of ophthalmology, is published by the esteemed American Medical Association. Renowned for its rigorous peer-review process and commitment to advancing eye health research, JAMA Ophthalmology holds a prestigious position in the scientific community, boasting an impressive impact factor and ranking as Q1 in the category of Ophthalmology. With a Scopus rank of #3 out of 137 in its field and a remarkable 98th percentile, the journal serves as an invaluable resource for researchers, healthcare professionals, and students dedicated to the ophthalmic sciences. Readers can explore a wealth of cutting-edge findings, clinical studies, and review articles that not only contribute to the sustainable advancement of ophthalmic knowledge but also foster innovative approaches in patient care. As we converge into 2024, the journal continues to embrace open access principles, ensuring that groundbreaking research is readily available to a global audience, enhancing collaborative efforts and furthering the development of the ophthalmology discipline.

PROGRESS IN RETINAL AND EYE RESEARCH, published by PERGAMON-ELSEVIER SCIENCE LTD, is a premier journal dedicated to the advancement of knowledge in the fields of ophthalmology and sensory systems. With an impressive impact factor and a Q1 category ranking in both Ophthalmology and Sensory Systems as of 2023, this journal exemplifies excellence in research dissemination. Given its stature, it ranks #1 out of 137 in Ophthalmology and #1 out of 42 in Neuroscience - Sensory Systems, placing it within the top percentile of scientific publications in these domains. The journal has been actively contributing to the field since its inception in 1994 and continues to be a vital resource for researchers, clinicians, and students seeking the latest insights and breakthroughs in the understanding of retinal diseases and eye health. While it maintains a traditional subscription model, the journal remains committed to publishing high-quality, peer-reviewed articles that drive forward the frontiers of eye research and therapeutic innovation. With its strong scientific rigor and a vast array of articles, PROGRESS IN RETINAL AND EYE RESEARCH is indispensable for anyone invested in the study of visual sciences.